IFNA1 and neoplasm: To show definitively that IFNα/β production by the tumour or the stroma was not involved in mediating the in vivo resistance to MYXV, we reduced K1492's ability to respond to IFNα/β by silencing IRF9 with a shRNA construct transduced via lentiviral infection.